SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 27 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,686 | -34.2% | 112,900 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $128,706 | -24.0% | 112,900 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $169,350 | +0.7% | 112,900 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $168,221 | -33.2% | 112,900 | -30.7% | 0.00% | -42.9% |
| Q3 2022 | $252,000 | +193.0% | 162,900 | +329.8% | 0.01% | +250.0% |
| Q2 2022 | $86,000 | -2.3% | 37,900 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $88,000 | – | 37,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Duquesne Family Office | 100,000 | $580,000 | 0.02% |
| Virtu Financial LLC | 15,980 | $93,000 | 0.01% |
| Jump Financial, LLC | 11,800 | $68,000 | 0.00% |
| Investment Research & Advisory Group, Inc. | 1,400 | $4,000 | 0.00% |
| Cubist Systematic Strategies, LLC | 12,804 | $74,000 | 0.00% |
| UBS Group AG | 22,402 | $130,000 | 0.00% |
| RHUMBLINE ADVISERS | 18,894 | $110,000 | 0.00% |
| Ellevest, Inc. | 18 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 28,771 | $167,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 11,105 | $64,000 | 0.00% |